Intrinsic Value of S&P & Nasdaq Contact Us

ETHZilla Corporation Warrant ATNFW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score
42/100
2/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

ETHZilla Corporation Warrant (ATNFW) is a publicly traded company in the Healthcare sector, operating within the Medical - Pharmaceuticals industry. The company is headquartered in Palo Alto, DE, United States. The current CEO is Lloyd Blair Jordan.

ATNFW has IPO date of 2017-06-27, 4 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $2.6M.

About ETHZilla Corporation Warrant

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.

📍 Building 4, Palo Alto, DE 94306 📞 650 507 0669
Company Details
SectorHealthcare
IndustryMedical - Pharmaceuticals
CountryUnited States
ExchangeNASDAQ Capital Marke
CurrencyUSD
IPO Date2017-06-27
CEOLloyd Blair Jordan
Employees4
Trading Info
Current Price$0.43
Market Cap$2.6M
52-Week Range0.36-0.4433
Beta0.41
ETFNo
ADRNo
CUSIP68236V104
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message